ArticleScientific reports2025
CT-based body composition and its demographic and clinical associations in women aged 20 to 40 with non-metastatic breast cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial intelligence standardizes CT-based body composition analysis in breast cacer to address methodological heterogeneity.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
This cross-sectional study investigated the relationship between CT-based body composition parameters and demographic and clinical factors in young women (< 40 years) with non-metastatic (I–III) breast cancer. Data on anthropometry, sociodemographic characteristics, and tumor profiles were extracted from medical records. Body composition was assessed using CT scans at the third lumbar vertebra (L3), measuring skeletal muscle cross-sectional area (SM), skeletal muscle index (SMI), skeletal muscle radiodensity (SMD), visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT). A total of 173 patients were included (mean age: 33.8 ± 4.1 years). Most women had stage III tumors and hormone receptor-positive status. Higher VAT levels were associated with older age (P = 0.001). A higher education level was associated with higher SAT values. Women with invasive ductal carcinoma or positive estrogen receptor status were less likely to have high VAT. Patients with high VAT and SAT had higher BMI, SM, and SMI, and lower SMD (all P < 0.005). Our findings suggest that SAT and VAT are associated with educational level and tumor aggressiveness, respectively, highlighting the importance of monitoring body composition as part of clinical care in young women with breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.